A LinkedIn post from Single Quantum highlights the company’s planned presence at the Focus on Microscopy 2026 conference in Stockholm. The post notes that Lead Application Engineer Hein Zijlstra is scheduled to present on March 31, 2026, about how the firm’s superconducting nanowire single-photon detectors, or SNSPDs, can broaden bio-imaging into the near-infrared and enable deep tissue imaging.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post also points to an on-site demonstration at Booth 30, where Single Quantum intends to showcase a microscopy solution integrating its photon detection technology with PicoQuant’s microscope. This combination is described as delivering high sensitivity and time resolution across visible, NIR and SWIR ranges for fluorescence lifetime imaging, suggesting a focus on advanced life-science imaging applications.
For investors, the conference activity may indicate Single Quantum’s ongoing push to position its SNSPD technology in high-value biomedical and microscopy markets. Visibility at a specialized event like Focus on Microscopy could support future sales opportunities and partnerships, particularly with research institutions and equipment manufacturers that prioritize performance in deep tissue and lifetime imaging.
The collaboration highlighted with PicoQuant may also signal a strategy of embedding Single Quantum’s detectors within established microscopy platforms rather than selling stand-alone components alone. If this approach gains traction, it could strengthen the company’s ecosystem ties, increase switching costs for customers, and potentially enhance revenue stability through system-level integrations and co-marketing efforts.